BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1693297)

  • 1. Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection.
    Miles SA; Mitsuyasu RT; Lee K; Moreno J; Alton K; Egrie JC; Souza L; Glaspy JA
    Blood; 1990 Jun; 75(11):2137-42. PubMed ID: 1693297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
    Miles SA; Mitsuyasu RT; Moreno J; Baldwin G; Alton NK; Souza L; Glaspy JA
    Blood; 1991 May; 77(10):2109-17. PubMed ID: 1709368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.
    Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A
    Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
    Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
    Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of erythropoietin and recombinant cytokines on colony formation and self-renewal by erythroid burst-forming units and granulocyte-macrophage progenitors from mobilized peripheral blood progenitor cells.
    Zheng B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):6-12. PubMed ID: 12513828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.
    Mitjavila MT; Natazawa M; Brignaschi P; Debili N; Breton-Gorius J; Vainchenker W
    J Cell Physiol; 1989 Mar; 138(3):617-23. PubMed ID: 2647773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
    Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
    Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias.
    Miles SA; Lee K; Hutlin L; Zsebo KM; Mitsuyasu RT
    Blood; 1991 Dec; 78(12):3200-8. PubMed ID: 1720698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 inhibits burst-forming unit-erythroid growth by suppression of endogenous granulocyte-macrophage colony-stimulating factor production from T cells.
    Oehler L; Kollars M; Bohle B; Berer A; Reiter E; Lechner K; Geissler K
    Exp Hematol; 1999 Feb; 27(2):217-23. PubMed ID: 10029159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of monocyte-macrophage colony-stimulating factor (M-CSF) on in vitro erythropoiesis of marrow progenitor cells from patients with renal anemia.
    Kawano Y; Takaue Y; Minakuchi J; Kawashima S; Kimura F; Motoyoshi K; Abe T; Sato J; Hirao A; Saito S
    Eur J Haematol; 1995 Mar; 54(3):147-52. PubMed ID: 7720833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood.
    Mizuguchi T; Kosaka M; Saito S
    Blood; 1993 Jun; 81(11):2891-7. PubMed ID: 8499628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.
    Rusten LS; Dybedal I; Blomhoff HK; Blomhoff R; Smeland EB; Jacobsen SE
    Blood; 1996 Mar; 87(5):1728-36. PubMed ID: 8634418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fusion protein MEN 11303 (granulocyte-macrophage colony stimulating factor/erythropoietin) acts as a potent inducer of erythropoiesis.
    Battaglia A; Fattorossi A; Pierelli L; Bonanno G; Marone M; Ranelletti FO; Coscarella A; De Santis R; Bach S; Mancuso S; Scambia G
    Exp Hematol; 2000 May; 28(5):490-8. PubMed ID: 10812238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of granulocyte-macrophage colony-stimulating factor and erythropoietin on leukemic erythroid colony formation in human early erythroblastic leukemias.
    Mitjavila MT; Villeval JL; Cramer P; Henri A; Gasson J; Krystal G; Tulliez M; Berger R; Breton-Gorius J; Vainchenker W
    Blood; 1987 Oct; 70(4):965-73. PubMed ID: 3498522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates.
    Umemura T; al-Khatti A; Donahue RE; Papayannopoulou T; Stamatoyannopoulos G
    Blood; 1989 Oct; 74(5):1571-6. PubMed ID: 2477080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 5-fluorouracil on erythropoiesis.
    Rich IN
    Blood; 1991 Mar; 77(6):1164-70. PubMed ID: 2001449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.